VanEck Biotech ETF
BBH
BBH
108 hedge funds and large institutions have $123M invested in VanEck Biotech ETF in 2020 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 34 increasing their positions, 20 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
108
Holders Change
+7
Holders Change %
+6.93%
% of All Funds
1.92%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
34
Reduced
20
Closed
6
Calls
$1.16M
Puts
$1.39M
Net Calls
-$234K
Net Calls Change
-$721K
Top Buyers
| 1 |
Goldman Sachs
New York
|
+$3.3M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$2.73M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.1M |
| 4 |
KAS
Kestra Advisory Services
Austin,
Texas
|
+$913K |
| 5 |
Cetera Investment Advisers
Schaumburg,
Illinois
|
+$593K |
Top Sellers
| 1 |
PAG
Pinnacle Advisory Group
Columbia,
Maryland
|
-$20.2M |
| 2 |
HighTower Advisors
Chicago,
Illinois
|
-$2.21M |
| 3 |
FTUS
Flow Traders U.S.
New York
|
-$946K |
| 4 |
LPL Financial
San Diego,
California
|
-$419K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$238K |
